LANCE VARNS: Open Payments
NPI 1962583534 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,690 in 109 payments from 21 companies in 2025. Trend: 2023 $2,761 · 2024 $1,643 · 2025 $2,690
Food & beverage: $2,502Education: $189
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $451 |
| Actelion Pharmaceuticals US, Inc. | 13 | $410 |
| GlaxoSmithKline, LLC. | 23 | $391 |
| Verona Pharma, Inc. | 6 | $229 |
| United Therapeutics Corporation | 4 | $171 |
| GENZYME CORPORATION | 9 | $160 |
| Merck Sharp & Dohme LLC | 5 | $142 |
| Baxter Healthcare | 10 | $138 |
| Insmed, Inc. | 3 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
Products named: DUPIXENT, TEZSPIRE, UPTRAVI, Ohtuvayre, NUCALA, AIRSUPRA, Hillrom - Vest System Model 105 Home Care, WINREVAIR.
Industry payments across WA — which companies pay providers there.
